Hjem › Kreft (alle typer) › Nebraska › Lincoln
Kliniske studier for Kreft (alle typer) i Lincoln, NE
3 studier for Kreft (alle typer) søker deltakere på steder i og rundt Lincoln (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 2/3
- Nho - Revive Research Institute /ID# 277569, Lincoln
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 2/3
- Nho - Revive Research Institute /ID# 276115, Lincoln
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- NHO Revive Research Institute, LLC /ID# 267869, Lincoln
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- New York City, NY109 studier
- Boston, MA85 studier
- Los Angeles, CA74 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Washington, DC58 studier
- Durham, NC58 studier
- Chicago, IL51 studier
- Atlanta, GA49 studier
- Seattle, WA49 studier
- Arlington, VA48 studier
Andre studier i Lincoln
- Ikke-småcellet lungekreft16 studier
- Hjertesvikt8 studier
- Lungekreft7 studier
- Koronararteriesykdom5 studier
- Schizofreni4 studier
- Brystkreft4 studier
- Kolorektal kreft4 studier
- Fedme4 studier
- Amyotrofisk lateralsklerose3 studier
- Multipelt myelom3 studier
- Melanom3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.